Treatment Extension of Pegylated Interferon Alpha and Ribavirin Does Not Improve SVR in Patients with Genotypes 2/3 without Rapid Virological Response (OPTEX Trial): A Prospective, Randomized, Two-Arm, Multicentre Phase IV Clinical Trial

Benjamin Heidrich, Hans-Jörg Cordes, Hartwig Klinker, Bernd Möller, Uwe Naumann, Martin Rössle, Michael R Kraus, Klaus H Böker, Christoph Roggel, Marcus Schuchmann, Albrecht Stoehr, Andreas Trein, Svenja Hardtke, Andrea Gonnermann, Armin Koch, Heiner Wedemeyer, Michael P Manns and Markus Cornberg

PLOS ONE, 2015, vol. 10, issue 6, 1-17

Abstract: Trial Registration: ClinicalTrials.gov NCT00803309

Date: 2015
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0128069 (text/html)
https://journals.plos.org/plosone/article/file?id= ... 28069&type=printable (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:plo:pone00:0128069

DOI: 10.1371/journal.pone.0128069

Access Statistics for this article

More articles in PLOS ONE from Public Library of Science
Bibliographic data for series maintained by plosone ().